Jiangsu Hengrui Medicine
600276.SS
#455
Rank
NZ$93.51 B
Marketcap
NZ$14.09
Share price
0.84%
Change (1 day)
5.68%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): NZ$0.25

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is NZ$0.25. In 2025 the company made an earnings per share (EPS) of NZ$0.29 an increase over its 2024 EPS that were of NZ$0.24.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.25-14.09%
2025NZ$0.2924.14%
2024NZ$0.2442.43%
2023NZ$0.178.77%
2022NZ$0.15-20.62%
2021NZ$0.19-26.59%
2020NZ$0.2627.24%
2019NZ$0.2128.41%
2018NZ$0.1620.04%
2017NZ$0.1331.21%
2016NZ$0.1011.46%
2015NZ$0.0910136.27%
2014NZ$0.0667919.77%
2013NZ$0.0557618.05%
2012NZ$0.0472423.9%
2011NZ$0.0381226.9%
2010NZ$0.0300412.37%
2009NZ$0.0267456.6%
2008NZ$0.017079.18%
2007NZ$0.01564114.48%
2006NZ$0.00729164.83%
2005NZ$0.00442335.55%
2004NZ$0.00326329.73%
2003NZ$0.00251519.86%
2002NZ$0.002099-2.71%
2001NZ$0.0021571.02%
2000NZ$0.002135